Research programme: antibody-drug conjugates - Immunome/pH Pharma
Alternative Names: ADC - Immunome/pH PharmaLatest Information Update: 28 Nov 2023
At a glance
- Originator Immunome; pH Pharma
- Class Antibodies; Antineoplastics; Drug conjugates; Immunoconjugates; Immunotoxins
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Nov 2023 No recent reports of development identified for research development in Cancer in South Korea (Parenteral)
- 28 Nov 2023 No recent reports of development identified for research development in Cancer in USA (Parenteral)
- 21 Oct 2019 Immunome and pH Pharma enter into research and development agreement for Cancer